Impact of the Opioid Epidemic and Associated Prescribing Restrictions on People Who Live With Chronic Noncancer Pain in Canada

被引:5
作者
Kabore, Jean-Luc [1 ,2 ]
Page, M. Gabrielle [2 ,3 ]
Martel, Marc O. [4 ,5 ,7 ]
Dassieu, Lise [2 ]
Hudspith, Maria [6 ]
Moor, Gregg [6 ]
Sutton, Kathryn [6 ]
Roy, Jean-Sebastien [6 ,7 ,8 ]
Williamson, Owen D. [1 ,9 ,10 ]
Choiniere, Manon [2 ,3 ]
机构
[1] Univ Montreal, Fac Med, Dept Pharmacol & Physiol, Montreal, PQ, Canada
[2] Univ Montreal, Fac Med, Dept Anesthesiol & Pain Med, Montreal, PQ, Canada
[3] Univ Montreal Hosp Ctr CRCHUM, Res Ctr, Vancouver, BC, Canada
[4] McGill Univ, Dept Anesthesia, Fac Med, Fac Dent, Montreal, PQ, Canada
[5] McGill Univ, Alan Edwards Ctr Res Pain, Montreal, PQ, Canada
[6] Pain BC Soc, Vancouver, BC, Canada
[7] Univ Laval, Fac Med, Ctr Interdisciplinary Res Rehhabil & Social Integ, Laval, PQ, Canada
[8] Univ Laval, Fac Med, Dept Rehabil, Laval, PQ, Canada
[9] JPOCSC Pain Management Clin, Fraser Hlth Author, Surrey, BC, Canada
[10] Monash Univ, Dept Epidemiol & Prevent Med, Clayton, Vic, Australia
关键词
chronic noncancer pain; opioid epidemic; pain management; opioids; BRITISH-COLUMBIA; UNITED-STATES; TRENDS; PREVALENCE; PRESCRIPTIONS; INTERFERENCE; MEDICATION; MANAGEMENT; GUIDELINE; THERAPY;
D O I
10.1097/AJP.0000000000000951
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Objectives: Little is known about the consequences of the opioid epidemic on people living with chronic noncancer pain (CNCP). This study examined this issue in people who lived in the most impacted province by opioid overdoses in Canada (British Columbia [BC]) or one of the least impacted (Quebec [QC]), and examined the factors associated with opioid use. Materials and Methods: This cross-sectional study was carried out in adults living in BC (N=304) and QC (N=1071) who reported CNCP (>= 3 months) and completed an online questionnaire that was tailored to their opioid status. Results: Almost twice as many participants in BC as in QC were proposed to cease their opioid medication in the past year (P<0.001). The proportion who reported having hoarded opioids in fear of not being able to get more in the future was also significantly higher in BC (P<0.001) compared with QC. In addition, they were significantly more likely to have had their opioid dose decreased than those in QC (P=0.001). No significant association was found between opioid discontinuation and province of residence. Two-thirds of the BC participants felt that the media coverage of the opioid crisis was very to extremely detrimental to CNCP patients in general, this percentage being significantly higher than in QC (P<0.001). Discussion: The opioid epidemic and associated prescribing restrictions have had harmful effects on Canadians with CNCP. The clinical community, the general public, and the media need to be aware of these negative consequences to decrease patients' stigmatization and minimize inadequate treatment of CNCP.
引用
收藏
页码:607 / 615
页数:9
相关论文
共 65 条
[21]   Painful lives: Chronic pain experience among people who use illicit drugs in Montreal (Canada) [J].
Dassieu, Lise ;
Kabore, Jean-Luc ;
Choiniere, Manon ;
Arruda, Nelson ;
Roy, Elise .
SOCIAL SCIENCE & MEDICINE, 2020, 246
[22]   Understanding stigma and chronic pain: a-state-of-the-art review [J].
De Ruddere, Lies ;
Craig, Kenneth D. .
PAIN, 2016, 157 (08) :1607-1610
[23]   CDC Guideline for Prescribing Opioids for Chronic Pain-United States, 2016 [J].
Dowell, Deborah ;
Haegerich, Tamara M. ;
Chou, Roger .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 315 (15) :1624-1645
[24]   A review of chronic pain impact on patients, their social environment and the health care system [J].
Duenas, Maria ;
Ojeda, Begona ;
Salazar, Alejandro ;
Antonio Mico, Juan ;
Failde, Inmaculada .
JOURNAL OF PAIN RESEARCH, 2016, 9 :457-467
[25]   Core outcome measures for chronic pain clinical trials: IMMPACT recommendations [J].
Dworkin, RH ;
Turk, DC ;
Farrar, JT ;
Haythornthwaite, JA ;
Jensen, MP ;
Katz, NP ;
Kerns, RD ;
Stucki, G ;
Allen, RR ;
Bellamy, N ;
Carr, DB ;
Chandler, J ;
Cowan, P ;
Dionne, R ;
Galer, BS ;
Hertz, S ;
Jadad, AR ;
Kramer, LD ;
Manning, DC ;
Martin, S ;
McCormick, CG ;
McDermott, MP ;
McGrath, P ;
Quessy, S ;
Rappaport, BA ;
Robbins, W ;
Robinson, JP ;
Rothman, M ;
Royal, MA ;
Simon, L ;
Stauffer, JW ;
Stein, W ;
Tollett, J ;
Wernicke, J ;
Witter, J .
PAIN, 2005, 113 (1-2) :9-19
[26]  
Fischer B, 2018, PAIN PHYSICIAN, V21, P219
[27]   Revisiting the "paradigm shift' in opioid use: Developments and implications 10years later [J].
Fischer, Benedikt ;
Rehm, Juergen .
DRUG AND ALCOHOL REVIEW, 2018, 37 :S199-S202
[28]   Non-medical use of prescription opioids and prescription opioid-related harms: why so markedly higher in North America compared to the rest of the world? [J].
Fischer, Benedikt ;
Keates, Annette ;
Buehringer, Gerhard ;
Reimer, Jens ;
Rehm, Juergen .
ADDICTION, 2014, 109 (02) :177-181
[29]   Differences and over-time changes in levels of prescription opioid analgesic dispensing from retail pharmacies in Canada, 2005-2010 [J].
Fischer, Benedikt ;
Jones, Wayne ;
Krahn, Murray ;
Rehm, Juergen .
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 (12) :1269-1277
[30]   New Canadian guidance on opioid use for chronic pain: necessary but not sufficient [J].
Furlan, Andrea D. ;
Williamson, Owen D. .
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2017, 189 (18) :E650-E651